Transmucosal Drug Delivery Pipeline Report 2024 - Stages Of Development, Segments, Region And Countries, Regulatory Path And Key Companies

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's offering.
The Medical Devices sector report provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Report Scope

• Extensive coverage of the Transmucosal Drug Delivery under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Transmucosal Drug Delivery and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Transmucosal Drug Delivery under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transmucosal Drug Delivery Overview
3 Products under Development
3.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
3.2 Transmucosal Drug Delivery - Pipeline Products by Segment
3.3 Transmucosal Drug Delivery - Pipeline Products by Territory
3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials
4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies
4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
5 Transmucosal Drug Delivery Companies and Product Overview
6 Transmucosal Drug Delivery- Recent Developments
A selection of companies mentioned in this report includes

• AFYX Therapeutics
• Albert Einstein College of Medicine
• Allergan Ltd
• Altamira Medica
• Amphastar Pharmaceuticals Inc
• Anelleo Inc
• Aquestive Therapeutics Inc
• Arovella Therapeutics Ltd
• ARS Pharmaceuticals Inc
• Atossa Therapeutics Inc
• Auris Medical AG
• Auritec Pharmaceuticals Inc
• BeFree!
• Bespak Europe Ltd
• Biorings LLC
• BioXcel Therapeutics Inc
• Birmingham Biotech Ltd
• Bryn Pharma
• Chulalongkorn University
• Combinent BioMedical Systems Inc
• Conrad
• Covidrops
• CS Medica
• Dare Bioscience
• Eledon Pharmaceuticals Inc
• Emergent BioSolutions Inc
• EmphyCorp Inc
• Ena Respiratory Pty Ltd
• Eureka Therapeutics Inc
• Eveon SAS
• Evestra Inc
• Evofem Biosciences Inc
• Ferring Pharmaceuticals
• Firebrick Pharma Pty Ltd
• GeneOne Life Science Inc
• Ghent University
• Glenmark Pharmaceuticals Ltd
• Grasses of Eden Ltd
• Grunenthal Ltd
• Halberd Corp
• Hebrew University of Jerusalem
• Hikma Pharmaceuticals Plc
• Hovione FarmaCiencia SA
• Imbed Biosciences Inc
• Indivior Plc
• Institute for Research and Innovation in Health
• IntelGenx Corp
• International Partnership For Microbicides
• ITC Life Sciences and Technology Centre
• ITF Pharma Inc
• Janssen Sciences Ireland UC
• Kane Biotech Inc
• Karessa Pharma AB
• Karp Lab
• Kiora Pharmaceuticals Inc
• Kurve Therapeutics Inc
• Kytogenics Pharmaceuticals Inc
• Laboratoire HRA Pharma SAS
• Lachesis Biosciences Ltd
• Leyden Laboratories BV
• Lobe Sciences Ltd
• Lyra Therapeutics Inc
• Magee-Womens Research Institute
• MassBiologics
• McNeil AB
• Medlab Clinical Ltd
• Merck & Co Inc
• Merck Serono SA
• Milestone Pharmaceuticals USA Inc
• Mucommune LLC
• Mycrodose Therapeutics Inc
• Mystic Pharmaceuticals Inc
• Nanosys Inc
• Nasus Medical Inc
• Nasus Pharma Ltd
• Nemera La Verpilliere
• NorInvent AB
• Novlead Biotechnology Co Ltd
• Olfax LLC
• Opiant Pharmaceuticals Inc
• OptiNose AS
• OptiNose Inc
• Organon Pharma (UK) Ltd
• Orion Biotechnology Canada Ltd
• Orphanse Healthcare SAS
• Oyster Point Pharma Inc
• P&B Group
• Palette Life Sciences AB
• Parnell Pharmaceuticals Inc
• pHOXBIO Ltd
• Pocket Naloxone Corp
• Polyrizon Ltd
• Renown Pharmaceuticals Pvt Ltd
• Rhinomed Ltd
• Sanotize Research and Development Corp
• Seelos Therapeutics, Inc.
• Shin Nippon Biomedical Laboratories Ltd
• SipNose
• South Valley University
• Starpharma Holdings Ltd
• Talphera Inc
• The Population Council Inc
• Therakind Ltd
• Transire Bio
• Union Therapeutics
• Virpax Pharmaceuticals Inc
• VistaGen Therapeutics Inc
• Washington University in St Louis
• Wellfully Ltd
• Xlear Inc
• Zydus Healthcare Ltd

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

MENAFN12112024004107003653ID1108876754